GUILDFORD, SURREY / ACCESSWIRE / May 25, 2022 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, is absolutely delighted to announce that the US Food and Drug ...

ANGLE ACHIEVES WORLD FIRST WITH FDA CLEARANCE FOR ITS PARSORTIX SYSTEM FDADe Novo product clearance to harvest cancer cells from blood for subsequent analysis offers the prospect of a new era of ...

GUILDFORD, SURREY / ACCESSWIRE / March 4, 2021 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that, following substantive review of ANGLE's FDA submission ...

Detailed price information for Angle Plc ADR (ANPCY) from The Globe and Mail including charting and trades.

UPDATE ON SUBMISSION FOR FDA CLEARANCE OF THE PARSORTIX SYSTEM Response to Additional Information Request made to FDA as planned GUILDFORD, UK / ACCESSWIRE / June 4, 2021 / ANGLE plc (OTCQX:ANPCY ...

UPDATE ON SUBMISSION FOR FDA CLEARANCE OF THE PARSORTIX SYSTEM Additional Information Request received from FDA as expected and ANGLE response being prepared in line with expected timescales FDA has.